Should You Buy BioNano Genomics Inc (BNGO) Stock Wednesday Morning?

BioNano Genomics Inc (BNGO) is lower by Wednesday morning, with the stock declining -0.83% in pre-market trading to 3.59. BNGO's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Diagnostics & Research industry, which ranks 117 out of 146 industries, BioNano Genomics Inc ranks higher than 74% of stocks. BioNano Genomics Inc has fallen 34.42% over the past month, closing at $4.99 on November 10. During this period of time, the stock fell as low as $3.34 and as high as $5.23. BNGO has an average analyst recommendation of Strong Buy. The company has an average price target of $12.00.

BNGO has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on BNGO!

See Full BNGO Report

BioNano Genomics Inc has a Long-Term Technical rank of 30. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 70% of the market scoring higher. In the Diagnostics & Research industry which is number 127 by this metric, BNGO ranks better than 46% of stocks.

Important Dates for Investors in BNGO:

-BioNano Genomics Inc is set to release earnings on 2/2/2022. During their last earnings release the company posted EPS of $-0.23. -We do not have a set dividend date for BioNano Genomics Inc at this time. Click Here To Get The Full Report on BioNano Genomics Inc (BNGO)